Advertisement

Hematopoietic Cell Transplantation for the Treatment of Patients with Bone Marrow Failure Syndromes

  • Andrew C. Dietz
  • Michael A. Pulsipher
Chapter
Part of the Pediatric Oncology book series (PEDIATRICO)

Abstract

Bone marrow failure, either acquired or inherited, is often treated by hematopoietic cell transplantation (HCT). The treatment algorithm for severe aplastic anemia is going through an evolution as newer reduced intensity approaches aimed at balancing and minimizing graft failure, graft-versus-host disease (GVHD), and transplant-related morbidity and mortality have resulted in excellent outcomes with limited late effects. Many patients with inherited bone marrow failure syndromes have increased sensitivity related to the underlying diagnosis or because of comorbidities due to previous therapies. Tailored approaches to each syndrome have been developed, with most patients now surviving. Only now are we starting to understand long-term sequelae that these patients face as a result of underlying diagnosis, previous treatments, and HCT combined. This chapter reviews the current approaches to transplantation in severe aplastic anemia, Fanconi anemia, dyskeratosis congenita, Diamond-Blackfan anemia, Shwachman-Diamond syndrome, severe congenital neutropenia, and congenital amegakaryocytic thrombocytopenia. The forthcoming role of gene therapy is also discussed.

Keywords

Hematopoietic cell transplantation Fanconi anemia Dyskeratosis congenita Diamond-Blackfan anemia Shwachman-Diamond syndrome Severe congenital neutropenia Congenital amegakaryocytic thrombocytopenia 

References

  1. Adair JE, Zhao X, Chien S, Fang M, Wohlfahrt ME, Trobridge GD et al (2012) Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities. J Mol Med (Berl) 90(11):1283–1294. e-pub ahead of print 2012/06/03.  https://doi.org/10.1007/s00109-012-0905-0 CrossRefGoogle Scholar
  2. Agarwal S, Loh YH, McLoughlin EM, Huang J, Park IH, Miller JD et al (2010) Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464(7286):292–296.  https://doi.org/10.1038/nature08792 CrossRefPubMedPubMedCentralGoogle Scholar
  3. Algeri M, Comoli P, Strocchio L, Perotti C, Corbella F, Del Fante C et al (2015) Successful T-cell-depleted haploidentical hematopoietic stem cell transplantation in a child with dyskeratosis congenita after a fludarabine-based conditioning regimen. J Pediatr Hematol Oncol 37(4):322–326.  https://doi.org/10.1097/MPH.0000000000000283 CrossRefPubMedGoogle Scholar
  4. Alter BP (2007) Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program:29–39. e-pub ahead of print 2007/11/21.  https://doi.org/10.1182/asheducation-2007.1.29 CrossRefGoogle Scholar
  5. Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin JH et al (2015) Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study. Lancet Haematol 2(9):e367–e375.  https://doi.org/10.1016/S2352-3026(15)00147-7 CrossRefPubMedPubMedCentralGoogle Scholar
  6. Anur P, Friedman DN, Sklar C, Oeffinger K, Castiel M, Kearney J et al (2016) Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors. Bone Marrow Transplant 51(7):938–944.  https://doi.org/10.1038/bmt.2016.32 CrossRefPubMedPubMedCentralGoogle Scholar
  7. Aoki T, Koh K, Ikeda Y, Sekinaka Y, Akiyama K, Mori M et al (2016) Addition of high-dose cytarabine to fludarabine-based conditioning for hematopoietic stem cell transplantation for treating Fanconi anemia patients with advanced myeloid malignancy: a single-center experience and literature review. Biol Blood Marrow Transplant 22(9):1725–1728. e-pub ahead of print 2016/05/28.  https://doi.org/10.1016/j.bbmt.2016.05.021 CrossRefPubMedGoogle Scholar
  8. Asquith JM, Copacia J, Mogul MJ, Bajwa RP (2015) Successful use of reduced-intensity conditioning and matched-unrelated hematopoietic stem cell transplant in a child with Diamond-Blackfan anemia and cirrhosis. Pediatr Transplant 19(6):E157–E159. e-pub ahead of print 2015/06/23.  https://doi.org/10.1111/petr.12547 CrossRefPubMedGoogle Scholar
  9. Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, Al-Seraihi A, Tbakhi A et al (2005) Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy. Bone Marrow Transplant 35(5):463–466.  https://doi.org/10.1038/sj.bmt.1704787 CrossRefPubMedGoogle Scholar
  10. Ayas M, Al-Seraihi A, El-Solh H, Al-Ahmari A, Khairy A, Aldali A et al (2012) The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells. Biol Blood Marrow Transplant 18(4):627–632. e-pub ahead of print 2011/08/24.  https://doi.org/10.1016/j.bbmt.2011.08.015 CrossRefPubMedGoogle Scholar
  11. Ayas M, Saber W, Davies SM, Harris RE, Hale GA, Socie G et al (2013) Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia. J Clin Oncol 31(13):1669–1676. e-pub ahead of print 2013/04/01.  https://doi.org/10.1200/JCO.2012.45.9719 CrossRefPubMedPubMedCentralGoogle Scholar
  12. Ayas M, Siddiqui K, Al-Jefri A, El-Solh H, Al-Ahmari A, Khairy A et al (2014) Factors affecting the outcome of related allogeneic hematopoietic cell transplantation in patients with Fanconi Anemia. Biol Blood Marrow Transplant 20(10):1599–1603. e-pub ahead of print 2014/06/21.  https://doi.org/10.1016/j.bbmt.2014.06.016 CrossRefPubMedGoogle Scholar
  13. Bacigalupo A (2014) Bone marrow transplantation for acquired severe aplastic anemia. Hematol Oncol Clin North Am 28(6):1145–1155. e-pub ahead of print 2014/12/03.  https://doi.org/10.1016/j.hoc.2014.08.004 CrossRefPubMedGoogle Scholar
  14. Bacigalupo A, Socie G, Schrezenmeier H, Tichelli A, Locasciulli A, Fuehrer M et al (2012) Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica 97(8):1142–1148. e-pub ahead of print 2012/02/09.  https://doi.org/10.3324/haematol.2011.054841 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Bacigalupo A, Socie G, Hamladji RM, Aljurf M, Maschan A, Kyrcz-Krzemien S et al (2015) Current outcome of HLA identical sibling vs. unrelated donor transplants in severe aplastic anemia: an EBMT analysis. Haematologica. e-pub ahead of print 2015/01/27.  https://doi.org/10.3324/haematol.2014.115345 CrossRefGoogle Scholar
  16. Ballmaier M, Germeshausen M (2011) Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost 37(6):673–681. e-pub ahead of print 2011/11/18.  https://doi.org/10.1055/s-0031-1291377 CrossRefPubMedGoogle Scholar
  17. Barbaro P, Vedi A (2016) Survival after hematopoietic stem cell transplant in patients with dyskeratosis congenita: systematic review of the literature. Biol Blood Marrow Transplant 22(7):1152–1158.  https://doi.org/10.1016/j.bbmt.2016.03.001 CrossRefPubMedGoogle Scholar
  18. Beier R, Maecker-Kolhoff B, Sykora KW, Chao M, Kratz C, Sauer MG (2015) Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML. Bone Marrow Transplant 50(3):463–464. e-pub ahead of print 2014/12/22.  https://doi.org/10.1038/bmt.2014.283 CrossRefPubMedGoogle Scholar
  19. Benajiba L, Salvado C, Dalle JH, Jubert C, Galambrun C, Soulier J et al (2015) HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine. Blood 125(2):417–418.  https://doi.org/10.1182/blood-2014-10-605113 CrossRefPubMedGoogle Scholar
  20. Berndt A, Helwig A, Ehninger G, Bornhäuser M (2005) Successful transplantation of CD34+ selected peripheral blood stem cells from an unrelated donor in an adult patient with Diamond-Blackfan anemia and secondary hemochromatosis. Bone Marrow Transplant 35(1):99–100.  https://doi.org/10.1038/sj.bmt.1704700 CrossRefPubMedGoogle Scholar
  21. Bhatla D, Davies SM, Shenoy S, Harris RE, Crockett M, Shoultz L et al (2008) Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. Bone Marrow Transplant 42(3):159–165. e-pub ahead of print 2008/05/26.  https://doi.org/10.1038/bmt.2008.151 CrossRefPubMedGoogle Scholar
  22. Bizzetto R, Bonfim C, Rocha V, Socié G, Locatelli F, Chan K et al (2011) Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia. Haematologica 96(1):134–141. e-pub ahead of print 2010/11/11.  https://doi.org/10.3324/haematol.2010.027839 CrossRefPubMedGoogle Scholar
  23. Bonfim C, Ribeiro L, Nichele S, Bitencourt M, Loth G, Koliski A et al (2016) Long-term survival, organ function, and malignancy after hematopoietic stem cell transplantation for Fanconi anemia. Biol Blood Marrow Transplant 22(7):1257–1263.  https://doi.org/10.1016/j.bbmt.2016.03.007 CrossRefPubMedGoogle Scholar
  24. Boulad F, Gillio A, Small TN, George D, Prasad V, Torok-Castanza J et al (2000) Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol 111(4):1153–1157CrossRefGoogle Scholar
  25. Brown M, Myers D, Shreve N, Rahmetullah R, Radhi M (2016) Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita. Bone Marrow Transplant 51(5):744–746.  https://doi.org/10.1038/bmt.2015.333 CrossRefPubMedGoogle Scholar
  26. Burroughs L, Woolfrey A, Shimamura A (2009) Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am 23(2):233–248.  https://doi.org/10.1016/j.hoc.2009.01.007 CrossRefPubMedPubMedCentralGoogle Scholar
  27. Burroughs LM, Woolfrey AE, Storer BE, Deeg HJ, Flowers ME, Martin PJ et al (2012) Success of allogeneic marrow transplantation for children with severe aplastic anaemia. Br J Haematol 158(1):120–128. e-pub ahead of print 2012/04/27.  https://doi.org/10.1111/j.1365-2141.2012.09130.x CrossRefPubMedPubMedCentralGoogle Scholar
  28. Carlsson G, Winiarski J, Ljungman P, Ringdén O, Mattsson J, Nordenskjöld M et al (2011) Hematopoietic stem cell transplantation in severe congenital neutropenia. Pediatr Blood Cancer 56(3):444–451.  https://doi.org/10.1002/pbc.22836 CrossRefPubMedGoogle Scholar
  29. Cesaro S, Oneto R, Messina C, Gibson BE, Buzyn A, Steward C et al (2005) Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation. Br J Haematol 131(2):231–236.  https://doi.org/10.1111/j.1365-2141.2005.05758.x CrossRefPubMedGoogle Scholar
  30. Chan KW, McDonald L, Lim D, Grimley MS, Grayson G, Wall DA (2008) Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia. Bone Marrow Transplant 42(9):589–595.  https://doi.org/10.1038/bmt.2008.227 CrossRefPubMedGoogle Scholar
  31. Chao MM, Kuehl JS, Strauss G, Hanenberg H, Schindler D, Neitzel H et al (2015) Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only. Ann Hematol 94(8):1311–1318.  https://doi.org/10.1007/s00277-015-2370-7 CrossRefPubMedGoogle Scholar
  32. Ciceri F, Lupo-Stanghellini MT, Korthof ET (2013) Haploidentical transplantation in patients with acquired aplastic anemia. Bone Marrow Transplant 48(2):183–185. e-pub ahead of print 2013/01/08.  https://doi.org/10.1038/bmt.2012.231 CrossRefPubMedGoogle Scholar
  33. Clay J, Kulasekararaj AG, Potter V, Grimaldi F, McLornan D, Raj K et al (2014) Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia. Biol Blood Marrow Transplant 20(11):1711–1716. e-pub ahead of print 2014/07/13.  https://doi.org/10.1016/j.bbmt.2014.06.028 CrossRefPubMedGoogle Scholar
  34. Connelly JA, Choi SW, Levine JE (2012) Hematopoietic stem cell transplantation for severe congenital neutropenia. Curr Opin Hematol 19(1):44–51.  https://doi.org/10.1097/MOH.0b013e32834da96e CrossRefPubMedPubMedCentralGoogle Scholar
  35. D’Allard D, Liu J (2016) Towards RNA repair of Diamond-Blackfan anemia hematopoietic stem cells. Hum Gene Ther. e-pub ahead of print 2016/08/22.  https://doi.org/10.1089/hum.2016.081 CrossRefGoogle Scholar
  36. Dietz AC, Orchard PJ, Baker KS, Giller RH, Savage SA, Alter BP et al (2011) Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. Bone Marrow Transplant 46(1):98–104.  https://doi.org/10.1038/bmt.2010.65 CrossRefPubMedGoogle Scholar
  37. Dietz AC, Lucchini G, Samarasinghe S, Pulsipher MA (2016) Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia. Curr Opin Pediatr 28(1):3–11.  https://doi.org/10.1097/MOP.0000000000000299 CrossRefPubMedPubMedCentralGoogle Scholar
  38. Dietz AC, Duncan CN, Alter BP, Bresters D, Cowan MJ, Notarangelo L et al (2017a) The second pediatric blood and marrow transplant consortium international consensus conference on late effects after pediatric hematopoietic cell transplantation: defining the unique late effects of children undergoing hematopoietic cell transplantation for immune deficiencies, inherited marrow failure disorders, and hemoglobinopathies. Biol Blood Marrow Transplant 23(1):24–29. e-pub ahead of print 2016/10/11.  https://doi.org/10.1016/j.bbmt.2016.10.004 CrossRefPubMedGoogle Scholar
  39. Dietz AC, Mehta PA, Vlachos A, Savage SA, Bresters D, Tolar J et al (2017b) Current knowledge and priorities for future research in late effects after hematopoietic cell transplantation (HCT) for inherited bone marrow failure syndromes (IBMFS): consensus statement from the second pediatric blood and marrow transplant consortium international conference on late effects after pediatric HCT. Biol Blood Marrow Transplant. e-pub ahead of print 2017/01/20.  https://doi.org/10.1016/j.bbmt.2017.01.075 CrossRefGoogle Scholar
  40. Donadieu J, Michel G, Merlin E, Bordigoni P, Monteux B, Beaupain B et al (2005) Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry. Bone Marrow Transplant 36(9):787–792.  https://doi.org/10.1038/sj.bmt.1705141 CrossRefPubMedGoogle Scholar
  41. Dufort G, Pisano S, Incoronato A, Castiglioni M, Carracedo M, Pagés C et al (2012) Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay. Bone Marrow Transplant 47(5):663–668. e-pub ahead of print 2011/07/18.  https://doi.org/10.1038/bmt.2011.148 CrossRefPubMedGoogle Scholar
  42. Dufour C, Veys P, Carraro E, Bhatnagar N, Pillon M, Wynn R et al (2015) Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT. Br J Haematol. e-pub ahead of print 2015/08/01.  https://doi.org/10.1111/bjh.13614 CrossRefGoogle Scholar
  43. Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J et al (2011) Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. Blood 118(9):2618–2621. e-pub ahead of print 2011/06/17.  https://doi.org/10.1182/blood-2011-05-354001 CrossRefPubMedPubMedCentralGoogle Scholar
  44. Esteves I, Bonfim C, Pasquini R, Funke V, Pereira NF, Rocha V et al (2015) Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study. Bone Marrow Transplant 50(5):685–689. e-pub ahead of print 2015/03/03.  https://doi.org/10.1038/bmt.2015.20 CrossRefPubMedGoogle Scholar
  45. Fagioli F, Quarello P, Zecca M, Lanino E, Corti P, Favre C et al (2014) Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry. Br J Haematol 165(5):673–681. e-pub ahead of print 2014/02/24.  https://doi.org/10.1111/bjh.12787 CrossRefPubMedGoogle Scholar
  46. Fioredda F, Iacobelli S, van Biezen A, Gaspar B, Ancliff P, Donadieu J et al (2015) Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation. Blood 126(16):1885–1892.; quiz 1970. e-pub ahead of print 2015/07/16.  https://doi.org/10.1182/blood-2015-02-628859 CrossRefPubMedGoogle Scholar
  47. Flygare J, Olsson K, Richter J, Karlsson S (2008) Gene therapy of Diamond Blackfan anemia CD34(+) cells leads to improved erythroid development and engraftment following transplantation. Exp Hematol 36(11):1428–1435. e-pub ahead of print 2008/08/19.  https://doi.org/10.1016/j.exphem.2008.06.012 CrossRefPubMedGoogle Scholar
  48. Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M et al (2013) Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant 19(8):1238–1243. e-pub ahead of print 2013/06/12.  https://doi.org/10.1016/j.bbmt.2013.05.021 CrossRefPubMedPubMedCentralGoogle Scholar
  49. Gao L, Li Y, Zhang Y, Chen X, Zhang C, Liu Y et al (2014) Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy. Bone Marrow Transplant 49(4):519–524. e-pub ahead of print 2014/01/28.  https://doi.org/10.1038/bmt.2013.224 CrossRefPubMedGoogle Scholar
  50. Geddis AE (2009) Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Hematol Oncol Clin North Am 23(2):321–331.  https://doi.org/10.1016/j.hoc.2009.01.012 CrossRefPubMedPubMedCentralGoogle Scholar
  51. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J et al (2007) Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 13(9):1073–1082. e-pub ahead of print 2007/07/20.  https://doi.org/10.1016/j.bbmt.2007.05.015 CrossRefPubMedGoogle Scholar
  52. Gómez-Almaguer D, Ruiz-Argüelles GJ, Tarín-Arzaga LC, González-Llano O, Jaime-Pérez JC, López-Martínez B et al (2003) Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience. Biol Blood Marrow Transplant 9(3):157–161.  https://doi.org/10.1053/bbmt.2003.50004 CrossRefPubMedGoogle Scholar
  53. Gupta N, Choudhary D, Sharma SK, Khandelwal V, Dhamija M (2015) Haploidentical hematopoietic SCT for acquired severe aplastic anemia using post-transplant high-dose CY. Bone Marrow Transplant 50:155–156CrossRefGoogle Scholar
  54. Hasle H (2016) Myelodysplastic and myeloproliferative disorders of childhood. Hematology Am Soc Hematol Educ Program 2016(1):598–604.  https://doi.org/10.1182/asheducation-2016.1.598 CrossRefPubMedGoogle Scholar
  55. Im HJ, Koh KN, Seo JJ (2015) Haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia. Korean J Pediatr 58(6):199–205. e-pub ahead of print 2015/07/28.  https://doi.org/10.3345/kjp.2015.58.6.199 CrossRefPubMedPubMedCentralGoogle Scholar
  56. Jaing TH, Chen SH, Yang CP, Hung IJ, Chang TY, Hsueh C (2014) Successful hematopoietic reconstitution by unrelated donor cord blood transplantation in children with Fanconi anemia: report of 3 cases. J Pediatr Hematol Oncol 36(8):e553–e555.  https://doi.org/10.1097/MPH.0000000000000215 CrossRefPubMedGoogle Scholar
  57. Jaiswal SR, Chatterjee S, Mukherjee S, Ray K, Chakrabarti S (2015) Pre-transplant sirolimus might improve the outcome of haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide for patients with severe aplastic anemia. Bone Marrow Transplant 50:873–875CrossRefGoogle Scholar
  58. Kelly PF, Radtke S, von Kalle C, Balcik B, Bohn K, Mueller R et al (2007) Stem cell collection and gene transfer in Fanconi anemia. Mol Ther 15(1):211–219.  https://doi.org/10.1038/sj.mt.6300033 CrossRefPubMedGoogle Scholar
  59. Khan NE, Rosenberg PS, Lehmann HP, Alter BP (2015) Preemptive bone marrow transplantation for FANCD1/BRCA2. Biol Blood Marrow Transplant 21(10):1796–1801.  https://doi.org/10.1016/j.bbmt.2015.07.006 CrossRefPubMedPubMedCentralGoogle Scholar
  60. Khan NE, Rosenberg PS, Alter BP (2016) Preemptive bone marrow transplantation and event-free survival in Fanconi anemia. Biol Blood Marrow Transplant 22(10):1888–1892.  https://doi.org/10.1016/j.bbmt.2016.06.018 CrossRefPubMedPubMedCentralGoogle Scholar
  61. Kojima S, Horibe K, Inaba J, Yoshimi A, Takahashi Y, Kudo K et al (2000) Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation. Br J Haematol 111(1):321–328 e-pub ahead of print 2000/11/25 CrossRefGoogle Scholar
  62. Kuşkonmaz B, Ünal Ş, Bayhan T, Aytaç Eyüboğlu S, Tavil B, Çetin M et al (2016) Successful outcome with fludarabine-based conditioning regimen for hematopoietic stem cell transplantation from related donor in Fanconi anemia: a single center experience from Turkey. Pediatr Blood Cancer 63(4):695–700. e-pub ahead of print 2015/12/24.  https://doi.org/10.1002/pbc.25844 CrossRefPubMedGoogle Scholar
  63. Mackarel J, Iatan M, Kumar L, Storey L, O’Marcaigh A, Smith O (2016) In support of upfront stem cell transplantation as first-line therapy for paediatric patients with idiopathic severe aplastic anaemia who lack a sibling donor. Br J Haematol. e-pub ahead of print 2016/04/21.  https://doi.org/10.1111/bjh.14097 CrossRefGoogle Scholar
  64. MacMillan ML, DeFor TE, Young JA, Dusenbery KE, Blazar BR, Slungaard A et al (2015) Alternative donor hematopoietic cell transplantation for Fanconi anemia. Blood 125(24):3798–3804. e-pub ahead of print 2015/04/01.  https://doi.org/10.1182/blood-2015-02-626002 CrossRefPubMedPubMedCentralGoogle Scholar
  65. Mahadeo KM, Tewari P, Parikh SH, Driscoll TA, Page K, Martin PL et al (2015) Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation. Pediatr Transplant 19(7):753–757. e-pub ahead of print 2015/09/14.  https://doi.org/10.1111/petr.12577 CrossRefPubMedGoogle Scholar
  66. Mitchell R, Wagner JE, Hirsch B, DeFor TE, Zierhut H, MacMillan ML (2014) Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia. Br J Haematol 164(3):384–395. e-pub ahead of print 2013/10/30.  https://doi.org/10.1111/bjh.12634 CrossRefPubMedGoogle Scholar
  67. Mugishima H, Ohga S, Ohara A, Kojima S, Fujisawa K, Tsukimoto I et al (2007) Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology. Pediatr Transplant 11(6):601–607.  https://doi.org/10.1111/j.1399-3046.2006.00616.x CrossRefPubMedGoogle Scholar
  68. Muraoka K, Ishii E, Ihara K, Imayoshi M, Miyazaki S, Hara T et al (2005) Successful bone marrow transplantation in a patient with c-mpl-mutated congenital amegakaryocytic thrombocytopenia from a carrier donor. Pediatr Transplant 9(1):101–103.  https://doi.org/10.1111/j.1399-3046.2005.00247.x CrossRefPubMedGoogle Scholar
  69. Nelson AS, Marsh RA, Myers KC, Davies SM, Jodele S, O’Brien TA et al (2016) A reduced-intensity conditioning regimen for patients with dyskeratosis congenita undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 22(5):884–888.  https://doi.org/10.1016/j.bbmt.2016.01.026 CrossRefPubMedPubMedCentralGoogle Scholar
  70. Nishio N, Takahashi Y, Ohashi H, Doisaki S, Muramatsu H, Hama A et al (2011) Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita. Pediatr Transplant 15(2):161–166.  https://doi.org/10.1111/j.1399-3046.2010.01431.x CrossRefPubMedGoogle Scholar
  71. Osborn MJ, Gabriel R, Webber BR, DeFeo AP, McElroy AN, Jarjour J et al (2015) Fanconi anemia gene editing by the CRISPR/Cas9 system. Hum Gene Ther 26(2):114–126.  https://doi.org/10.1089/hum.2014.111 CrossRefPubMedGoogle Scholar
  72. Osone S, Imamura T, Fukushima-Nakase Y, Kitamura-Masaki A, Kanai S, Imai T et al (2016) Case reports of severe congenital neutropenia treated with unrelated cord blood transplantation with reduced-intensity conditioning. J Pediatr Hematol Oncol 38(1):49–52.  https://doi.org/10.1097/MPH.0000000000000487 CrossRefPubMedGoogle Scholar
  73. Ostronoff M, Florencio R, Campos G, Arruda S, Matias C, Florencio M et al (2004) Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia. Bone Marrow Transplant 34(4):371–372.  https://doi.org/10.1038/sj.bmt.1704592 CrossRefPubMedGoogle Scholar
  74. Park JY, Singh TR, Nassar N, Zhang F, Freund M, Hanenberg H et al (2014) Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair. Oncogene 33(40):4803–4812. e-pub ahead of print 2013/10/21.  https://doi.org/10.1038/onc.2013.421 CrossRefPubMedGoogle Scholar
  75. Peffault de Latour R, Soulier J (2016) How I treat MDS and AML in Fanconi anemia. Blood 127(24):2971–2979. e-pub ahead of print 2016/03/28.  https://doi.org/10.1182/blood-2016-01-583625 CrossRefPubMedGoogle Scholar
  76. Peffault de Latour R, Purtill D, Ruggeri A, Sanz G, Michel G, Gandemer V et al (2011) Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. Biol Blood Marrow Transplant 17(1):78–85. e-pub ahead of print 2010/06/22.  https://doi.org/10.1016/j.bbmt.2010.06.011 CrossRefPubMedGoogle Scholar
  77. Peffault de Latour R, Porcher R, Dalle JH, Aljurf M, Korthof ET, Svahn J et al (2013) Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood 122(26):4279–4286.  https://doi.org/10.1182/blood-2013-01-479733 CrossRefPubMedGoogle Scholar
  78. Rao AA, Gourde JA, Marri P, Galardy PJ, Khan SP, Rodriguez V (2015) Congenital amegakaryocytic thrombocytopenia: a case report of pediatric twins undergoing matched unrelated bone marrow transplantation. J Pediatr Hematol Oncol 37(4):304–306.  https://doi.org/10.1097/MPH.0000000000000247 CrossRefPubMedGoogle Scholar
  79. Rosenberg PS, Socié G, Alter BP, Gluckman E (2005) Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 105(1):67–73.  https://doi.org/10.1182/blood-2004-04-1652 CrossRefPubMedGoogle Scholar
  80. Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B et al (2006) The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 107(12):4628–4635. e-pub ahead of print 2006/02/23.  https://doi.org/10.1182/blood-2005-11-4370 CrossRefPubMedPubMedCentralGoogle Scholar
  81. Roy V, Pérez WS, Eapen M, Marsh JC, Pasquini M, Pasquini R et al (2005) Bone marrow transplantation for Diamond-Blackfan anemia. Biol Blood Marrow Transplant 11(8):600–608.  https://doi.org/10.1016/j.bbmt.2005.05.005 CrossRefPubMedGoogle Scholar
  82. Samarasinghe S, Webb DK (2012) How I manage aplastic anaemia in children. Br J Haematol 157(1):26–40.  https://doi.org/10.1111/j.1365-2141.2012.09058.x CrossRefPubMedGoogle Scholar
  83. Saracco P, Quarello P, Iori AP, Zecca M, Longoni D, Svahn J et al (2008) Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up. Br J Haematol 140:197–205CrossRefGoogle Scholar
  84. Sauer M, Zeidler C, Meissner B, Rehe K, Hanke A, Welte K et al (2007) Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome. Bone Marrow Transplant 39(3):143–147. e-pub ahead of print 2007/01/08.  https://doi.org/10.1038/sj.bmt.1705553 CrossRefPubMedGoogle Scholar
  85. Scheinberg P, Young NS (2012) How I treat acquired aplastic anemia. Blood 120(6):1185–1196.  https://doi.org/10.1182/blood-2011-12-274019 CrossRefPubMedPubMedCentralGoogle Scholar
  86. Schrezenmeier H, Marin P, Raghavachar A, McCann S, Hows J, Gluckman E et al (1993) Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. Br J Haematol 85(2):371–377 e-pub ahead of print 1993/10/01CrossRefGoogle Scholar
  87. Shimada A, Takahashi Y, Muramatsu H, Hama A, Ismael O, Narita A et al (2012) Excellent outcome of allogeneic bone marrow transplantation for Fanconi anemia using fludarabine-based reduced-intensity conditioning regimen. Int J Hematol 95(6):675–679. e-pub ahead of print 2012/04/22.  https://doi.org/10.1007/s12185-012-1079-9 CrossRefPubMedGoogle Scholar
  88. Smetsers SE, Smiers FJ, Bresters D, Sonnevelt MC, Bierings MB (2016) Four decades of stem cell transplantation for Fanconi anaemia in the Netherlands. Br J Haematol 174(6):952–961. e-pub ahead of print 2016/07/29.  https://doi.org/10.1111/bjh.14165 CrossRefPubMedGoogle Scholar
  89. Socie G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A (2000) Late clonal diseases of treated aplastic anemia. Semin Hematol 37(1):91–101 e-pub ahead of print 2000/02/17CrossRefGoogle Scholar
  90. Stepensky P, Shapira MY, Balashov D, Trakhtman P, Skorobogatova E, Rheingold L et al (2011) Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning. Biol Blood Marrow Transplant 17(9):1282–1288. e-pub ahead of print 2011/01/08.  https://doi.org/10.1016/j.bbmt.2011.01.001 CrossRefPubMedGoogle Scholar
  91. Storb R, Blume KG, O’Donnell MR, Chauncey T, Forman SJ, Deeg HJ et al (2001) Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood Marrow Transplant 7(1):39–44. e-pub ahead of print 2001/02/24.  https://doi.org/10.1053/bbmt.2001.v7.pm11215697 CrossRefPubMedGoogle Scholar
  92. Talbot A, Peffault de Latour R, Raffoux E, Buchbinder N, Vigouroux S, Milpied N et al (2014) Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia. Haematologica 99(10):e199–e200. e-pub ahead of print 2014/08/01.  https://doi.org/10.3324/haematol.2013.098954 CrossRefPubMedPubMedCentralGoogle Scholar
  93. Tan PL, Wagner JE, Auerbach AD, Defor TE, Slungaard A, Macmillan ML (2006) Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer 46(5):630–636.  https://doi.org/10.1002/pbc.20538 CrossRefPubMedGoogle Scholar
  94. Thakar MS, Bonfim C, Sandmaier BM, O’Donnell P, Ribeiro L, Gooley T et al (2012) Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia. Pediatr Hematol Oncol 29(6):568–578. e-pub ahead of print 2012/07/27.  https://doi.org/10.3109/08880018.2012.708708 CrossRefPubMedPubMedCentralGoogle Scholar
  95. Tolar J, Adair JE, Antoniou M, Bartholomae CC, Becker PS, Blazar BR et al (2011) Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting. Mol Ther 19(7):1193–1198. e-pub ahead of print 2011/05/03.  https://doi.org/10.1038/mt.2011.78 CrossRefPubMedPubMedCentralGoogle Scholar
  96. Tolar J, Becker PS, Clapp DW, Hanenberg H, de Heredia CD, Kiem HP et al (2012) Gene therapy for Fanconi anemia: one step closer to the clinic. Hum Gene Ther 23(2):141–144.  https://doi.org/10.1089/hum.2011.237 CrossRefPubMedPubMedCentralGoogle Scholar
  97. Vibhakar R, Radhi M, Rumelhart S, Tatman D, Goldman F (2005) Successful unrelated umbilical cord blood transplantation in children with Shwachman-Diamond syndrome. Bone Marrow Transplant 36(10):855–861.  https://doi.org/10.1038/sj.bmt.1705142 CrossRefPubMedGoogle Scholar
  98. Vlachos A, Muir E (2010) How I treat Diamond-Blackfan anemia. Blood 116(19):3715–3723. e-pub ahead of print 2010/07/22.  https://doi.org/10.1182/blood-2010-02-251090 CrossRefPubMedPubMedCentralGoogle Scholar
  99. Vlachos A, Federman N, Reyes-Haley C, Abramson J, Lipton JM (2001) Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Bone Marrow Transplant 27(4):381–386.  https://doi.org/10.1038/sj.bmt.1702784 CrossRefPubMedGoogle Scholar
  100. Vuong LG, Hemmati PG, Neuburger S, Terwey TH, Vulliamy T, Dokal I et al (2010) Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita. Acta Haematol 124(4):200–203.  https://doi.org/10.1159/000318721 CrossRefPubMedGoogle Scholar
  101. Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F et al (2007) Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 109(5):2256–2262. e-pub ahead of print 2006/10/14.  https://doi.org/10.1182/blood-2006-07-036657 CrossRefPubMedPubMedCentralGoogle Scholar
  102. Williams DA, Croop J, Kelly P (2005) Gene therapy in the treatment of Fanconi anemia, a progressive bone marrow failure syndrome. Curr Opin Mol Ther 7(5):461–466PubMedGoogle Scholar
  103. Woods G, Bajwa RP, Rose MJ (2014) Reduced intensity transplantation for congenital amegakaryocytic thrombocytopenia: report of a case and review of the literature. Pediatr Transplant 18(1):E31–E34. e-pub ahead of print 2013/10/14.  https://doi.org/10.1111/petr.12175 CrossRefPubMedGoogle Scholar
  104. Yabe M, Shimizu T, Morimoto T, Koike T, Takakura H, Tsukamoto H et al (2012) Matched sibling donor stem cell transplantation for Fanconi anemia patients with T-cell somatic mosaicism. Pediatr Transplant 16(4):340–345. e-pub ahead of print 2012/03/08.  https://doi.org/10.1111/j.1399-3046.2012.01669.x CrossRefPubMedGoogle Scholar
  105. Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y et al (2008) Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 14(9):1057–1063.  https://doi.org/10.1016/j.bbmt.2008.07.003 CrossRefPubMedGoogle Scholar
  106. Zecca M, Strocchio L, Pagliara D, Comoli P, Bertaina A, Giorgiani G et al (2014) HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia. Biol Blood Marrow Transplant 20(4):571–576. e-pub ahead of print 2014/01/22.  https://doi.org/10.1016/j.bbmt.2014.01.015 CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Andrew C. Dietz
    • 1
  • Michael A. Pulsipher
    • 1
  1. 1.Children’s Center for Cancer and Blood Disorders, Children’s Hospital Los AngelesUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations